Paper
0
651P Efficacy and safety outcomes of Phase II study of SCC244 in NSCLC patients harboring MET exon 14 skipping (METex14) mutations (GLORY study): Long-term follow-up analysis
Authors
Yao Yu,Jin Zhou
X. Li,K. Goto,Xia Min,Ji Cui,Lingying Wu,Jun Sakakibara‐Konishi,Yang Cao,Xueyi Dong,Lei Li,Yasuto Yoneshima,Caicun Zhou,Yi Zhang,Dandan Huang,Fĕi Li,Min Qin,Meng Li,Si L,Yinglan Yu,X Li,Cao Yang
+20 authors
,Fēi LiJournal
Published
Dec 1, 2024
Show more
Save
Tip0
TipSave